| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 73.77B | 77.37B | 73.85B | 67.67B | 61.71B | 52.73B |
| Gross Profit | 23.09B | 23.23B | 21.90B | 19.47B | 17.27B | 15.36B |
| EBITDA | 4.90B | 4.13B | 4.52B | 3.99B | 3.51B | 3.49B |
| Net Income | 1.28B | 1.21B | 1.46B | 1.38B | 669.00M | 1.39B |
Balance Sheet | ||||||
| Total Assets | 65.43B | 68.56B | 64.97B | 62.37B | 57.37B | 54.52B |
| Cash, Cash Equivalents and Short-Term Investments | 8.50B | 9.82B | 10.05B | 8.87B | 6.92B | 6.74B |
| Total Debt | 13.13B | 18.48B | 16.75B | 15.32B | 16.24B | 14.66B |
| Total Liabilities | 38.66B | 39.22B | 37.24B | 36.76B | 34.48B | 33.35B |
| Stockholders Equity | 24.48B | 26.82B | 25.26B | 23.18B | 20.70B | 19.22B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.22B | 127.00M | 3.17B | -998.00M | -2.53B |
| Operating Cash Flow | 0.00 | 843.00M | 1.81B | 4.33B | 66.00M | -1.18B |
| Investing Cash Flow | 0.00 | -2.88B | -1.55B | -1.22B | -1.17B | -4.53B |
| Financing Cash Flow | 0.00 | 985.00M | 282.00M | -1.76B | 823.00M | 5.55B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥43.46B | 9.64 | ― | 2.86% | 6.10% | 19.77% | |
78 Outperform | ¥29.10B | 9.99 | ― | 3.82% | 8.69% | 18.95% | |
65 Neutral | ¥5.13B | 8.27 | ― | 1.22% | 0.38% | 51.72% | |
65 Neutral | ¥94.45B | 21.35 | ― | 3.41% | 5.24% | -71.41% | |
65 Neutral | ¥82.42B | 11.45 | ― | 2.35% | 11.86% | 207.24% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
55 Neutral | ¥18.99B | 15.81 | ― | 1.93% | 4.76% | -17.51% |